GenSight Biologics S.A. (EPA:SIGHT)
France flag France · Delayed Price · Currency is EUR
0.0757
+0.0013 (1.75%)
Nov 12, 2026, 9:20 AM CET

GenSight Biologics Market Cap

GenSight Biologics has a market cap or net worth of €17.75 million as of November 11, 2026. It is the 37,003rd most valuable company in the world and the 462nd biggest in France. Its market cap has decreased by 26.33% in one year.

Market Cap
17.75M
Enterprise Value
28.92M
Revenue
-251.00K
Global Rank
Country Rank
#462 France
PE Ratio
n/a

Chart

Chart

Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 17.75M, a decrease of -92.96%. That is a compound annual growth rate of -22.63%.

History

DateMarket Cap% Change
Nov 12, 202617.75M-22.88%
Dec 31, 202523.02M-30.35%
Dec 31, 202433.05M28.79%
Dec 29, 202325.66M-83.46%
Dec 30, 2022155.20M-39.23%
Dec 31, 2021255.38M-16.09%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding